Study #2020-0425
COVID-19: WELL-BEING AND HRQOL IN CANCER PATIENTS WHO PARTICIPATED IN PRIOR BEHAVIORAL CLINICAL TRIALS
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This study uses questionnaires to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted health-related quality of life (HRQOL) and other areas such as COVID-19-specific psychological distress, disruptions to health care, finances and social interactions in cancer patients. The coronavirus disease 2019 (COVID-19) is an infectious disease that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The information learned from this study will guide the development of psychosocial programs to improve patient care and outcomes in cancer patients and survivors in the context of facing a global pandemic.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
COVID-19 Infection;Malignant Solid Neoplasm
Study phase:
Physician name:
Lorenzo Cohen
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-855-371-6974
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.